NCT00647933View on ClinicalTrials.gov

An Open-label, Single Center Trial to Assess the Pharmacokinetics, Pharmacodynamics and Safety of Org 36286 (P07004)

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

June 30, 2000

Primary Completion Date

December 31, 2000

Study Completion Date

December 31, 2000

Conditions
Infertility
Interventions
DRUG

Org 36286

Subcutaneous Org 36286

DRUG

Lyndiol®

Lyndiol® (50 μg ethinylestradiol + 2.5 mg lynestrenol) tablets orally once a day for 6 weeks.

All Listed Sponsors
lead

Organon and Co

INDUSTRY

NCT00647933 - An Open-label, Single Center Trial to Assess the Pharmacokinetics, Pharmacodynamics and Safety of Org 36286 (P07004) | Biotech Hunter | Biotech Hunter